Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123397332 | 12339733 | 2 | F | 2016 | 20160921 | 20160506 | 20160930 | EXP | US-AMGEN-USASL2016055401 | AMGEN | 66.00 | YR | E | F | Y | 89.80000 | KG | 20160929 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123397332 | 12339733 | 1 | PS | PROLIA | DENOSUMAB | 1 | Subcutaneous | 60 MG/ML, UNK | 125320 | SOLUTION FOR INJECTION | |||||||||
123397332 | 12339733 | 2 | SS | ELIQUIS | APIXABAN | 1 | Unknown | 5 MG, BID | 0 | 5 | MG | BID | |||||||
123397332 | 12339733 | 3 | C | ATIVAN | LORAZEPAM | 1 | 1 MG, TID AS NEEDED | 0 | 1 | MG | TID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123397332 | 12339733 | 1 | Osteoporosis |
123397332 | 12339733 | 2 | Coagulopathy |
123397332 | 12339733 | 3 | Anxiety |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123397332 | 12339733 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123397332 | 12339733 | Bone scan abnormal | |
123397332 | 12339733 | Haemorrhoidal haemorrhage | |
123397332 | 12339733 | Haemorrhoids | |
123397332 | 12339733 | Malaise |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123397332 | 12339733 | 1 | 20150722 | 0 |